LFWD Quote, Financials, Valuation and Earnings

Twist Bioscience Corp. has a net margin of -51.17% compared to Lifeward Ltd.'s net margin of -27.41%. Lifeward Ltd.'s return on equity of -150.63% beat Twist Bioscience Corp.'s return on equity of -16.74%.

Lifeward Ltd. has a consensus price target of $7.25, signalling upside risk potential of 1015.39%. On the other hand Twist Bioscience Corp. has an analysts' consensus of $35.88 which suggests that it could grow by 6.01%. Given that Lifeward Ltd. has higher upside potential than Twist Bioscience Corp., analysts believe Lifeward Ltd. is more attractive than Twist Bioscience Corp..

Lifeward Ltd. has a beta of 0.010, which suggesting that the stock is 99.011% less volatile than S&P 500. In comparison Twist Bioscience Corp. has a beta of 2.242, suggesting its more volatile than the S&P 500 by 124.157%.

Lifeward Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Twist Bioscience Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lifeward Ltd. pays -- of its earnings as a dividend. Twist Bioscience Corp. pays out -- of its earnings as a dividend.

Lifeward Ltd. quarterly revenues are $6.2M, which are smaller than Twist Bioscience Corp. quarterly revenues of $99M. Lifeward Ltd.'s net income of -$3.2M is higher than Twist Bioscience Corp.'s net income of -$27.1M. Notably, Lifeward Ltd.'s price-to-earnings ratio is -- while Twist Bioscience Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lifeward Ltd. is 0.31x versus 5.40x for Twist Bioscience Corp.. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of -51.17% compared to Lifeward Ltd.'s net margin of -862.39%. Lifeward Ltd.'s return on equity of -150.63% beat VolitionRX Ltd.'s return on equity of --.

Lifeward Ltd. has a consensus price target of $7.25, signalling upside risk potential of 1015.39%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 763.76%. Given that Lifeward Ltd. has higher upside potential than VolitionRX Ltd., analysts believe Lifeward Ltd. is more attractive than VolitionRX Ltd..

Lifeward Ltd. has a beta of 0.010, which suggesting that the stock is 99.011% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

Lifeward Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lifeward Ltd. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

Lifeward Ltd. quarterly revenues are $6.2M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Lifeward Ltd.'s net income of -$3.2M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Lifeward Ltd.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lifeward Ltd. is 0.31x versus 17.45x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision, Inc. has a net margin of -51.17% compared to Lifeward Ltd.'s net margin of -1037.17%. Lifeward Ltd.'s return on equity of -150.63% beat Catheter Precision, Inc.'s return on equity of -192.05%.

Lifeward Ltd. has a consensus price target of $7.25, signalling upside risk potential of 1015.39%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1999.51%. Given that Catheter Precision, Inc. has higher upside potential than Lifeward Ltd., analysts believe Catheter Precision, Inc. is more attractive than Lifeward Ltd..

Lifeward Ltd. has a beta of 0.010, which suggesting that the stock is 99.011% less volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.

Lifeward Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lifeward Ltd. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.

Lifeward Ltd. quarterly revenues are $6.2M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Lifeward Ltd.'s net income of -$3.2M is lower than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Lifeward Ltd.'s price-to-earnings ratio is -- while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lifeward Ltd. is 0.31x versus 8.51x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -51.17% compared to Lifeward Ltd.'s net margin of 3.93%. Lifeward Ltd.'s return on equity of -150.63% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Lifeward Ltd. has a consensus price target of $7.25, signalling upside risk potential of 1015.39%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 92.31%. Given that Lifeward Ltd. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Lifeward Ltd. is more attractive than Xtant Medical Holdings, Inc..

Lifeward Ltd. has a beta of 0.010, which suggesting that the stock is 99.011% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

Lifeward Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Lifeward Ltd. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Lifeward Ltd. quarterly revenues are $6.2M, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Lifeward Ltd.'s net income of -$3.2M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Lifeward Ltd.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 76.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Lifeward Ltd. is 0.31x versus 0.85x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.